{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:40:56Z","timestamp":1792762856615,"version":"4.5.0"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T00:00:00Z","timestamp":1792713600000},"content-version":"vor","delay-in-days":99,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-62400-x","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T16:24:39Z","timestamp":1784219079000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Missense but mis-spliced: germline TP53 variant c.671A\u2009&gt;\u2009C (p.E224A) and the path from uncertainty to pathogenicity"],"prefix":"10.1038","volume":"16","author":[{"given":"Irena","family":"Velkova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Cappato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Rivera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferruccio","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Sch\u00f6negger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Bocciardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Reymer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre","family":"Hainaut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"De Marco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viviana","family":"Gismondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Cirmena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ludovica","family":"Menta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marzia","family":"Ognibene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Garaventa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Manzitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Brugnara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yari","family":"Ciribilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Bisio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Marcaccini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Malatesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Faravelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Menichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Capra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"62400_CR1","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1038\/278261a0","volume":"278","author":"DP Lane","year":"1979","unstructured":"Lane, D. P. & Crawford, L. V. T antigen is bound to a host protein in SV40-transformed cells. Nature 278, 261\u2013263 (1979).","journal-title":"Nature"},{"key":"62400_CR2","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/0042-6822(79)90554-3","volume":"98","author":"DI Linzer","year":"1979","unstructured":"Linzer, D. I., Maltzman, W. & Levine, A. J. The SV40 A gene product is required for the production of a 54,000 MW cellular tumor antigen. Virology 98, 308\u2013318 (1979).","journal-title":"Virology"},{"key":"62400_CR3","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/358015a0","volume":"358","author":"DP Lane","year":"1992","unstructured":"Lane, D. P. Cancer. p53, guardian of the genome. Nature 358, 15\u201316 (1992).","journal-title":"Nature"},{"key":"62400_CR4","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrc2723","volume":"9","author":"AJ Levine","year":"2009","unstructured":"Levine, A. J. & Oren, M. The first 30 years of p53: Growing ever more complex. Nat. Rev. Cancer 9, 749\u2013758 (2009).","journal-title":"Nat. Rev. Cancer"},{"key":"62400_CR5","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1016\/j.ccell.2024.04.009","volume":"42","author":"Y Liu","year":"2024","unstructured":"Liu, Y., Su, Z., Tavana, O. & Gu, W. Understanding the complexity of p53 in a new era of tumor suppression. Cancer Cell 42, 946\u2013967 (2024).","journal-title":"Cancer Cell"},{"key":"62400_CR6","first-page":"5358","volume":"48","author":"FP Li","year":"1988","unstructured":"Li, F. P. et al. A cancer family syndrome in twenty-four kindreds. Cancer Res. 48, 5358\u20135362 (1988).","journal-title":"Cancer Res."},{"key":"62400_CR7","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1007\/s12672-024-01435-w","volume":"15","author":"M-S Hosseini","year":"2024","unstructured":"Hosseini, M.-S. Current insights and future directions of Li\u2013Fraumeni syndrome. Discov. Oncol. 15, 561 (2024).","journal-title":"Discov. Oncol."},{"key":"62400_CR8","doi-asserted-by":"publisher","first-page":"2161","DOI":"10.1007\/s10147-021-02011-w","volume":"26","author":"T Kumamoto","year":"2021","unstructured":"Kumamoto, T. et al. Medical guidelines for Li\u2013Fraumeni syndrome 2019, version 1.1. Int. J. Clin. Oncol. 26, 2161\u20132178 (2021).","journal-title":"Int. J. Clin. Oncol."},{"key":"62400_CR9","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1038\/sj.onc.1201889","volume":"16","author":"JM Flaman","year":"1998","unstructured":"Flaman, J. M. et al. Identification of human p53 mutations with differential effects on the bax and p21 promoters using functional assays in yeast. Oncogene 16, 1369\u20131372 (1998).","journal-title":"Oncogene"},{"key":"62400_CR10","doi-asserted-by":"publisher","first-page":"2527","DOI":"10.1038\/sj.onc.1202041","volume":"16","author":"CJ Di Como","year":"1998","unstructured":"Di Como, C. J. & Prives, C. Human tumor-derived p53 proteins exhibit binding site selectivity and temperature sensitivity for transactivation in a yeast-based assay. Oncogene 16, 2527\u20132539 (1998).","journal-title":"Oncogene"},{"key":"62400_CR11","doi-asserted-by":"publisher","first-page":"3573","DOI":"10.1038\/sj.onc.1204468","volume":"20","author":"P Campomenosi","year":"2001","unstructured":"Campomenosi, P. et al. P53 mutants can often transactivate promoters containing a p21 but not bax or PIG3 responsive elements. Oncogene 20, 3573\u20133579 (2001).","journal-title":"Oncogene"},{"key":"62400_CR12","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1038\/sj.onc.1204116","volume":"20","author":"A Inga","year":"2001","unstructured":"Inga, A., Monti, P., Fronza, G., Darden, T. & Resnick, M. A. P53 mutants exhibiting enhanced transcriptional activation and altered promoter selectivity are revealed using a sensitive, yeast-based functional assay. Oncogene 20, 501\u2013513 (2001).","journal-title":"Oncogene"},{"key":"62400_CR13","doi-asserted-by":"publisher","first-page":"8424","DOI":"10.1073\/pnas.1431692100","volume":"100","author":"S Kato","year":"2003","unstructured":"Kato, S. et al. Understanding the function-structure and function-mutation relationships of p53 tumor suppressor protein by high-resolution missense mutation analysis. Proc. Natl. Acad. Sci. U. S. A. 100, 8424\u20138429 (2003).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"62400_CR14","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1002\/humu.22514","volume":"35","author":"A Bisio","year":"2014","unstructured":"Bisio, A., Ciribilli, Y., Fronza, G., Inga, A. & Monti, P. TP53 mutants in the tower of babel of cancer progression. Hum. Mutat. 35, 689\u2013701 (2014).","journal-title":"Hum. Mutat."},{"key":"62400_CR15","doi-asserted-by":"publisher","first-page":"1635","DOI":"10.1093\/carcin\/bgaa117","volume":"41","author":"Y Stein","year":"2020","unstructured":"Stein, Y., Aloni-Grinstein, R. & Rotter, V. Mutant p53 oncogenicity: Dominant-negative or gain-of-function?. Carcinogenesis 41, 1635\u20131647 (2020).","journal-title":"Carcinogenesis"},{"key":"62400_CR16","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1126\/science.aax3649","volume":"365","author":"S Boettcher","year":"2019","unstructured":"Boettcher, S. et al. A dominant-negative effect drives selection of TP53 missense mutations in myeloid malignancies. Science 365, 599\u2013604 (2019).","journal-title":"Science"},{"key":"62400_CR17","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1038\/s41588-018-0204-y","volume":"50","author":"AO Giacomelli","year":"2018","unstructured":"Giacomelli, A. O. et al. Mutational processes shape the landscape of TP53 mutations in human cancer. Nat. Genet. 50, 1381\u20131387 (2018).","journal-title":"Nat. Genet."},{"key":"62400_CR18","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.molcel.2018.06.012","volume":"71","author":"E Kotler","year":"2018","unstructured":"Kotler, E. et al. A systematic p53 mutation library links differential functional impact to cancer mutation pattern and evolutionary conservation. Mol. Cell 71, 178-190.e8 (2018).","journal-title":"Mol. Cell"},{"key":"62400_CR19","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1038\/s41588-024-02039-4","volume":"57","author":"JS Funk","year":"2025","unstructured":"Funk, J. S. et al. Deep CRISPR mutagenesis characterizes the functional diversity of TP53 mutations. Nat. Genet. 57, 140\u2013153 (2025).","journal-title":"Nat. Genet."},{"key":"62400_CR20","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1002\/pbc.21796","volume":"52","author":"V Capra","year":"2009","unstructured":"Capra, V. et al. Identification of a novel TP53 germline mutation in a large Italian Li\u2013Fraumeni syndrome family. Pediatr. Blood Cancer 52, 303\u2013304 (2009).","journal-title":"Pediatr. Blood Cancer"},{"key":"62400_CR21","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1158\/1541-7786.MCR-10-0496","volume":"9","author":"P Monti","year":"2011","unstructured":"Monti, P. et al. Dominant-negative features of mutant TP53 in germline carriers have limited impact on cancer outcomes. Mol. Cancer Res. 9, 271\u2013279 (2011).","journal-title":"Mol. Cancer Res."},{"key":"62400_CR22","doi-asserted-by":"publisher","first-page":"3789","DOI":"10.1158\/1078-0432.CCR-06-2545","volume":"13","author":"P Monti","year":"2007","unstructured":"Monti, P. et al. Transcriptional functionality of germ line p53 mutants influences cancer phenotype. Clin. Cancer Res. 13, 3789\u20133795 (2007).","journal-title":"Clin. Cancer Res."},{"key":"62400_CR23","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s13045-022-01332-1","volume":"15","author":"J Penkert","year":"2022","unstructured":"Penkert, J. et al. Genotype-phenotype associations within the Li-Fraumeni spectrum: A report from the German registry. J. Hematol. Oncol. 15, 107 (2022).","journal-title":"J. Hematol. Oncol."},{"key":"62400_CR24","doi-asserted-by":"publisher","first-page":"111296","DOI":"10.1016\/j.isci.2024.111296","volume":"27","author":"E Montellier","year":"2024","unstructured":"Montellier, E. et al. Clustering of TP53 variants into functional classes correlates with cancer risk and identifies different phenotypes of Li\u2013Fraumeni syndrome. iScience 27, 111296 (2024).","journal-title":"iScience"},{"key":"62400_CR25","doi-asserted-by":"publisher","first-page":"1379","DOI":"10.1038\/s41431-020-0638-4","volume":"28","author":"T Frebourg","year":"2020","unstructured":"Frebourg, T. et al. Guidelines for the Li\u2013Fraumeni and heritable TP53-related cancer syndromes. Eur. J. Hum. Genet. 28, 1379\u20131386 (2020).","journal-title":"Eur. J. Hum. Genet."},{"key":"62400_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.cancergen.2020.09.002","volume":"248\u2013249","author":"C Fortuno","year":"2020","unstructured":"Fortuno, C. et al. Genotype-phenotype correlations among TP53 carriers: Literature review and analysis of probands undergoing multi-gene panel testing and single-gene testing. Cancer Genet. 248\u2013249, 11\u201317 (2020).","journal-title":"Cancer Genet."},{"key":"62400_CR27","doi-asserted-by":"publisher","first-page":"1787","DOI":"10.1016\/S1470-2045(21)00580-5","volume":"22","author":"KC de Andrade","year":"2021","unstructured":"de Andrade, K. C. et al. Cancer incidence, patterns, and genotype-phenotype associations in individuals with pathogenic or likely pathogenic germline TP53 variants: An observational cohort study. Lancet Oncol. 22, 1787\u20131798 (2021).","journal-title":"Lancet Oncol."},{"key":"62400_CR28","doi-asserted-by":"publisher","first-page":"pkaf008","DOI":"10.1093\/jncics\/pkaf008","volume":"9","author":"LJ M\u00fcntnich","year":"2025","unstructured":"M\u00fcntnich, L. J. et al. Cancer risk in carriers of TP53 germline variants grouped into different functional categories. JNCI Cancer Spectr. 9, pkaf008 (2025).","journal-title":"JNCI Cancer Spectr."},{"key":"62400_CR29","doi-asserted-by":"publisher","first-page":"3664","DOI":"10.3390\/cancers14153664","volume":"14","author":"V Rocca","year":"2022","unstructured":"Rocca, V., Blandino, G., D\u2019Antona, L., Iuliano, R. & Di Agostino, S. Li\u2013Fraumeni syndrome: Mutation of TP53 is a biomarker of hereditary predisposition to tumor: New insights and advances in the treatment. Cancers (Basel) 14, 3664 (2022).","journal-title":"Cancers (Basel)"},{"key":"62400_CR30","doi-asserted-by":"publisher","first-page":"2345","DOI":"10.1200\/JCO.2014.59.5728","volume":"33","author":"G Bougeard","year":"2015","unstructured":"Bougeard, G. et al. Revisiting Li\u2013Fraumeni syndrome from TP53 mutation carriers. J. Clin. Oncol. 33, 2345\u20132352 (2015).","journal-title":"J. Clin. Oncol."},{"key":"62400_CR31","doi-asserted-by":"publisher","first-page":"2068","DOI":"10.1093\/annonc\/mdy333","volume":"29","author":"A Kron","year":"2018","unstructured":"Kron, A. et al. Impact of TP53 mutation status on systemic treatment outcome in ALK-rearranged non-small-cell lung cancer. Ann. Oncol. 29, 2068\u20132075 (2018).","journal-title":"Ann. Oncol."},{"key":"62400_CR32","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/humu.24152","volume":"42","author":"C Fortuno","year":"2021","unstructured":"Fortuno, C. et al. Specifications of the ACMG\/AMP variant interpretation guidelines for germline TP53 variants. Hum. Mutat. 42, 223\u2013236 (2021).","journal-title":"Hum. Mutat."},{"key":"62400_CR33","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/s13073-025-01536-3","volume":"17","author":"C Fortuno","year":"2025","unstructured":"Fortuno, C. et al. A quantitative, Bayesian-informed approach to gene-specific variant classification: Updated expert panel recommendations improve classification of TP53 germline variants for Li\u2013Fraumeni syndrome. Genome Med. 17, 128 (2025).","journal-title":"Genome Med."},{"key":"62400_CR34","doi-asserted-by":"publisher","DOI":"10.1101\/2023.08.01.551439","author":"IC Lock","year":"2023","unstructured":"Lock, I. C. et al. Mis-splicing drives loss of function of p53E224D point mutation. bioRxiv https:\/\/doi.org\/10.1101\/2023.08.01.551439 (2023).","journal-title":"bioRxiv"},{"key":"62400_CR35","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1186\/s40246-024-00714-5","volume":"19","author":"C Fortuno","year":"2025","unstructured":"Fortuno, C. et al. Exploring the role of splicing in TP53 variant pathogenicity through predictions and minigene assays. Hum. Genomics 19, 2 (2025).","journal-title":"Hum. Genomics"},{"key":"62400_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41431-026-02061-6","author":"D Sch\u00f6negger","year":"2026","unstructured":"Sch\u00f6negger, D. et al. Tumor patterns and cancer risk in carriers of TP53 exonic germline variants that alter mRNA splicing. Eur. J. Hum. Genet. https:\/\/doi.org\/10.1038\/s41431-026-02061-6 (2026).","journal-title":"Eur. J. Hum. Genet."},{"key":"62400_CR37","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1016\/j.leukres.2007.06.022","volume":"32","author":"S Pekova","year":"2008","unstructured":"Pekova, S. et al. Identification of a novel, transactivation-defective splicing variant of p53 gene in patients with chronic lymphocytic leukemia. Leuk. Res. 32, 395\u2013400 (2008).","journal-title":"Leuk. Res."},{"key":"62400_CR38","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.leukres.2010.12.016","volume":"35","author":"S Pekova","year":"2011","unstructured":"Pekova, S. et al. A comprehensive study of TP53 mutations in chronic lymphocytic leukemia: Analysis of 1287 diagnostic and 1148 follow-up CLL samples. Leuk. Res. 35, 889\u2013898 (2011).","journal-title":"Leuk. Res."},{"key":"62400_CR39","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1136\/jmg-2024-110449","volume":"62","author":"J Louis","year":"2025","unstructured":"Louis, J. et al. Li\u2013Fraumeni syndrome: A germline TP53 splice variant reveals a novel physiological alternative transcript. J. Med. Genet. 62, 160\u2013168 (2025).","journal-title":"J. Med. Genet."},{"key":"62400_CR40","doi-asserted-by":"publisher","first-page":"a003921","DOI":"10.1101\/mcs.a003921","volume":"5","author":"EA Quinn","year":"2019","unstructured":"Quinn, E. A. et al. From uncertainty to pathogenicity: Clinical and functional interrogation of a rare TP53 in-frame deletion. Cold Spring Harb. Mol. Case Stud. 5, a003921 (2019).","journal-title":"Cold Spring Harb. Mol. Case Stud."},{"key":"62400_CR41","doi-asserted-by":"publisher","first-page":"e164","DOI":"10.1093\/nar\/gkq603","volume":"38","author":"K Wang","year":"2010","unstructured":"Wang, K., Li, M. & Hakonarson, H. ANNOVAR: Functional annotation of genetic variants from high-throughput sequencing data. Nucleic Acids Res. 38, e164 (2010).","journal-title":"Nucleic Acids Res."},{"key":"62400_CR42","doi-asserted-by":"publisher","first-page":"8612","DOI":"10.1128\/MCB.22.24.8612-8625.2002","volume":"22","author":"A Inga","year":"2002","unstructured":"Inga, A., Storici, F., Darden, T. A. & Resnick, M. A. Differential transactivation by the p53 transcription factor is highly dependent on p53 level and promoter target sequence. Mol. Cell. Biol. 22, 8612\u20138625 (2002).","journal-title":"Mol. Cell. Biol."},{"key":"62400_CR43","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/0378-1119(95)00223-S","volume":"161","author":"TC Burn","year":"1995","unstructured":"Burn, T. C., Connors, T. D., Klinger, K. W. & Landes, G. M. Increased exon-trapping efficiency through modifications to the pSPL3 splicing vector. Gene 161, 183\u2013187 (1995).","journal-title":"Gene"},{"key":"62400_CR44","doi-asserted-by":"publisher","first-page":"3963","DOI":"10.1073\/pnas.92.9.3963","volume":"92","author":"JM Flaman","year":"1995","unstructured":"Flaman, J. M. et al. A simple p53 functional assay for screening cell lines, blood, and tumors. Proc. Natl. Acad. Sci. U. S. A. 92, 3963\u20133967 (1995).","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"62400_CR45","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1038\/sj.onc.1200952","volume":"14","author":"A Inga","year":"1997","unstructured":"Inga, A. et al. Determining mutational fingerprints at the human p53 locus with a yeast functional assay: A new tool for molecular epidemiology. Oncogene 14, 1307\u20131313 (1997).","journal-title":"Oncogene"},{"key":"62400_CR46","doi-asserted-by":"publisher","first-page":"e1006360","DOI":"10.1371\/journal.pcbi.1006360","volume":"14","author":"D Garrido-Mart\u00edn","year":"2018","unstructured":"Garrido-Mart\u00edn, D., Palumbo, E., Guig\u00f3, R. & Breschi, A. Ggsashimi: Sashimi plot revised for browser- and annotation-independent splicing visualization. PLoS Comput. Biol. 14, e1006360 (2018).","journal-title":"PLoS Comput. Biol."},{"key":"62400_CR47","doi-asserted-by":"publisher","unstructured":"Velkova, I. et al. Missense but mis-spliced: Germline TP53 variant c.671A>C (p.E224A) and the path from uncertainty to pathogenicity. Preprint at https:\/\/doi.org\/10.1101\/2025.07.31.25332437 (2025).","DOI":"10.1101\/2025.07.31.25332437"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62400-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62400-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62400-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T13:15:45Z","timestamp":1792761345000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-62400-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":47,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["62400"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-62400-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"assertion":[{"value":"9 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"33693"}}